ASX:VHT - Volpara Health Tech Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Volpara Health Tech Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add A$1.22 +0.08 (+7.02 %) (As of 04/2/2020 05:22 AM ET) Add Compare Today's RangeA$1.08Now: A$1.22▼A$1.2350-Day RangeA$0.81MA: A$1.34▼A$1.8052-Week RangeA$0.99Now: A$1.22▼A$2.17Volume544,606 shsAverage VolumeN/AMarket Capitalization$266.04 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. The company offers VolparaEnterprise software, a cloud based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements. It also offers VolparaDose that computes woman's personal X-ray dose based on specific breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; and VolparaPositioning that automatically assesses the positioning of the patient, as well as VolparaServer products. The company operates in the Asia Pacific, Europe, the Middle East, Africa, the United States, and Canada. The company was formerly known as matakina Technology Ltd. Volpara Health Technologies Limited was founded in 2009 and is based in Wellington, New Zealand.Read More Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:VHT Previous Symbol CUSIPN/A CIKN/A Webhttp://volparasolutions.com/ PhoneN/ADebt Debt-to-Equity Ratio5.87 Current Ratio3.58 Quick Ratio3.56Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.08 per share Price / Book15.64Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares218,062,000Market Cap$266.04 million Next Earnings DateN/A OptionableOptionable Receive VHT News and Ratings via Email Sign-up to receive the latest news and ratings for VHT and its competitors with MarketBeat's FREE daily newsletter. Volpara Health Tech (ASX:VHT) Frequently Asked Questions How has Volpara Health Tech's stock been impacted by COVID-19 (Coronavirus)? Volpara Health Tech's stock was trading at A$1.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VHT stock has increased by 7.0% and is now trading at A$1.22. View which stocks have been mosted impacted by Coronavirus. Has Volpara Health Tech been receiving favorable news coverage? News stories about VHT stock have been trending very negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Volpara Health Tech earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutVolpara Health Tech. Who are some of Volpara Health Tech's key competitors? Some companies that are related to Volpara Health Tech include Integral Diagnostics (IDX), Senseonics (SENS), Profound Medical (PRN), Exagen (XGN), Akumin (AKU), Renalytix Ai (RENX), Yourgene Health (YGEN), Palatin Technologies (PTN), Oncosil Medical (OSL), MaxCyte (MXCT), BARD1 Life Sciences (BD1), Lexagene (LXG), Oncimmune (ONC), SQI Diagnostics (SQD) and GeneNews (GEN). What other stocks do shareholders of Volpara Health Tech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Volpara Health Tech investors own include Sabre Resources (SBR), South32 (S32) and Auscann Group (AC8). Who are Volpara Health Tech's key executives? Volpara Health Tech's management team includes the following people: Dr. Ralph Highnam, CEO, Chief Scientist, Exec. Director & Member of Scientific BoardMr. Craig Hadfield, CFO & Joint Company Sec.Mr. David Murray Ph.D., Chief Technology OfficerMr. Mark Koeniguer, Chief Commercial Officer & Pres of USAMr. Julian Marshall, Chief Product Officer What is Volpara Health Tech's stock symbol? Volpara Health Tech trades on the ASX under the ticker symbol "VHT." What is Volpara Health Tech's stock price today? One share of VHT stock can currently be purchased for approximately A$1.22. How big of a company is Volpara Health Tech? Volpara Health Tech has a market capitalization of $266.04 million. View additional information about Volpara Health Tech. What is Volpara Health Tech's official website? The official website for Volpara Health Tech is http://volparasolutions.com/. MarketBeat Community Rating for Volpara Health Tech (ASX VHT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 10 (Vote Outperform)Underperform Votes: 9 (Vote Underperform)Total Votes: 19MarketBeat's community ratings are surveys of what our community members think about Volpara Health Tech and other stocks. Vote "Outperform" if you believe VHT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VHT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/2/2020 by MarketBeat.com StaffFeatured Article: Why Invest in Dividend Achievers?
